We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
A synthetic peptide derived of the β<sub>2</sub>–β<sub>3</sub> loop of the plant defensin from Vigna unguiculata seeds induces Leishmania amazonensis apoptosis-like cell death.
- Authors
Souza, Géssika Silva; de Carvalho, Laís Pessanha; de Melo, Edésio José Tenório; da Silva, Flávia Camila Vieira; Machado, Olga Lima Tavares; Gomes, Valdirene Moreira; de Oliveira Carvalho, André
- Abstract
For medical use of proteins and peptide-based drugs, it is desirable to have small biologically active sequences because they improve stability, reduce side effects, and production costs. Several plant defensins have their biological activities imparted by a sequence named γ-core. Vu-Def, a Vigna unguiculata defensin, has activity against Leishmania amazonensis, which is one etiological agent of leishmaniasis and for which new drugs are needed. Our intention was to understand if the region comprising the Vu-Def γ-core is responsible for the biological activity against L. amazonensis and to unveil its mechanism of action. Different microbiological assays with L. amazonensis in the presence of the synthetic peptide A36,42,44γ32-46Vu-Def were done, as well as ultrastructural and fluorescent analyses. A36,42,44γ32-46Vu-Def showed biological activity similar to Vu-Def. A36,42,44γ32-46Vu-Def (74 µM) caused 97% inhibition of L. amazonensis culture and parasites were unable to regrow in fresh medium. The cells of the treated parasites showed morphological alterations by ultrastructural analysis and fluorescent labelings that corroborate with the data of the organelles alterations. The general significance of our work is based on the description of a small synthetic peptide, A36,42,44γ32-46Vu-Def, which has activity on L. amazonensis and that the interaction between A36,42,44γ32-46Vu-Def-L. amazonensis results in parasite inhibition by the activation of an apoptotic-like cell death pathway.
- Subjects
CELL death; COWPEA; MICROBIOLOGICAL assay; SEEDS; BCL genes; INDUSTRIAL costs; PROTEIN drugs; DRUG stability
- Publication
Amino Acids, 2019, Vol 51, Issue 10-12, p1633
- ISSN
0939-4451
- Publication type
Article
- DOI
10.1007/s00726-019-02800-8